NCT05463497 - To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

March 16, 2022

Study Completion Date

March 23, 2022

Conditions

Healthy

Interventions

DRUG

Treatment A

JW0201: single administration, Tablet, Oral, BID for 5 days

DRUG

Treatment B

C2103: single administration, Tablet, Oral, BID for 5 days

DRUG

Treatment C

JW0201 and C2103 : combination administration, Tablet, Oral, BID for 5 days

DRUG

Treatment D

C2104 : single administration, Tablet, Oral, QD for 5 days

DRUG

Treatment E

JW0201 and C2104 : combination administration, JW0201 twice a day and C2104 once a day for 5days

Trial Locations (1)

Jeonbuk National University Hospita, Jeonju